TrialJournal of the European Academy of Dermatology and Venereology : JEADV2026

Efficacy and safety of brodalumab in palmoplantar pustulosis: A 68-week randomized Phase 3 trial.

Masamoto Murakami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.